Eli Lilly will test a drug to treat a coronavirus infection

Test results can be received in two months.

Eli Lilly begins testing the drug “Baricitinib,” used for the treatment of rheumatoid arthritis, to combat the coronavirus infection COVID-19.

The company agreed with the National Institute of Allergy and infectious diseases for clinical trials of “Baricitinib.” The tests will start in the US, continue in Europe and Asia, and the results will be available in two months.

Eli Lilly also indicated that it does not expect a shortage of this drug.

Author: Flyn Braun
Graduated from Cambridge University. Previously, he worked in various diferent news media. Currently, it is a columnist of the us news section in the Free News editors.
Function: Editor
E-mail: Braun.freenews@gmail.com